Abcam, ab266843, Human RAB13 knockout HEK-293T cell line

Size: 2 x 1000000Cells / vial / 1000000Cells / vial
RAB13 KO cell line available to order. KO validated by Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 7 bp deletion in exon 1. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.
Key facts
Cell type:HEK-293T,
Species or organism:Human,
Tissue:Kidney,
Form:LiquidSee storage information,
Knockout validation:Sanger Sequencing,Western blot,
Mutation description:Knockout achieved by using CRISPR/Cas9, Homozygous: 7 bp deletion in exon 1

Product details:
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-RAB13, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Western blot, Zygosity-Homozygous, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
RAB13 also known by the names YPT13 and RAB11FIP5 is a small GTPase from the RAB family with a molecular mass of approximately 23 kDa. It localizes to both the cytosol and various membrane compartments. Expressed broadly in different tissues including epithelial tissues and fibroblasts RAB13 plays an active role in vesicle trafficking processes. It primarily modulates the dynamics of vesicle formation transportation and fusion making it critical for maintaining cellular membrane identity and homeostasis.
Biological function summary
RAB13 influences cell surface dynamics by controlling the trafficking of proteins to the plasma membrane. It participates in forming complexes with other RAB proteins ensuring precise membrane delivery and recycling. As a result RAB13 assists in cell junction maintenance and tight junction stability enabling proper cell polarization and epithelial barrier function. This function is essential for processes like cell migration and tissue integrity.
Pathways
The role of RAB13 in intracellular trafficking links it to essential biological pathways such as the actin cytoskeleton regulation and the signaling of the epithelial-to-mesenchymal transition (EMT). In the actin regulation pathway RAB13 closely interacts with proteins like RHOA and CDC42 which assist in reorganizing the cytoskeleton essential for cell movement. For the EMT process RAB13 plays a part in modulating the cellular adherence and motility pathways which are critical during development and repair mechanisms.
The dysregulation of RAB13 expressions has connections to cancer progression and neurological disorders. Studies show that altered RAB13 activity can contribute to invasive cancer phenotypes such as in breast cancer by facilitating abnormal epithelial cell movement. Additionally improper RAB13 function links to neurological conditions where axonal transport is disrupted highlighting a connection with proteins like TAU which similarly plays a role in the maintenance of the neuronal cytoskeleton.